Abercrombie & Fitch price target lowered to $141 by JPMorgan

Published 16/06/2025, 14:58
Abercrombie & Fitch price target lowered to $141 by JPMorgan

JPMorgan lowered its price target on Abercrombie & Fitch (NYSE:ANF) stock to $141.00 from $147.00 on Monday, while maintaining an Overweight rating on the shares.

The price target adjustment came after JPMorgan hosted meetings with Abercrombie & Fitch executives, including CEO Fran Horowitz, COO Scott Lipesky, CFO Robert Ball (NYSE:BALL), and VP of Investor Relations Mo Gupta at the firm’s US All Stars Conference in Toronto.

JPMorgan noted that Abercrombie & Fitch is beginning "the next chapter of diversified agnostic revenue growth" with a focus on driving lifetime value of customers ranging from infants to 40-year-olds across the brand portfolio.

The retailer aims to achieve this growth strategy with "healthy incremental contribution margins across all segments," according to information shared during the investor meetings.

Despite the lower price target, JPMorgan’s maintained Overweight rating suggests the firm remains positive on Abercrombie & Fitch’s overall business outlook and potential for share appreciation.

In other recent news, Abercrombie & Fitch reported strong financial results for the first quarter of 2025, with earnings per share (EPS) of $1.59, surpassing the consensus expectation of $1.33. The company’s revenue reached a record $1.1 billion, marking an 8% increase year-over-year, although it slightly missed the forecasted $1.08 billion. The Hollister brand was a significant contributor, achieving a 22% rise in net sales. Despite a 10% drop in Abercrombie’s comparable sales, the company anticipates a rebound in the second half of the year. Citi analyst Paul Lejeuz raised the price target for Abercrombie & Fitch to $105, maintaining a Buy rating, citing strong sales and a favorable fiscal year 2025 outlook. Conversely, CFRA analyst Zachary Warring reduced the price target to $152 but kept a Strong Buy rating, noting the company’s undervaluation and potential for substantial shareholder returns. Raymond (NSE:RYMD) James also reiterated an Outperform rating with a $90 target, highlighting the company’s better-than-expected earnings and strategic cost management. Despite ongoing gross margin pressure, analysts remain optimistic about Abercrombie & Fitch’s future performance, backed by strong brand positioning and strategic initiatives.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.